Avivagen Inc. (CVE:VIV), a biotech stock, jumped after announcing that its partner in the Philippines has purchased a recurring, three-month supply of OxC-beta for Livestock
Sean Mason | August 16, 2017 | SmallCapPower
A purchase order from a Philippines partner injected a bit of buying interest into a biotech stock Wednesday. Here’s some small stocks making big moves on Wednesday, August 16, 2017 (as of 4 pm EST):
Avivagen Inc. (TSXV: VIV), a biotech stock, gained as much as 9% before closing up 4% to $1.20 on Wednesday after announcing that its partner in the Philippines, UNAHCO, has confirmed that it is scaling up, effective immediately, the commercial roll out of Avivagen’s OxC-beta for Livestock by purchasing a recurring, three-month supply at a time of OxC-beta for Livestock, for specific use in swine.
As well, shares of Atico Mining Corporation (TSXV: ATY) slipped 7% to $0.77 as the resource junior said there has been a temporary work stoppage at the El Roble mine in Colombia pending final inspection of the clean water discharge system.
Aveda Transportation and Energy Services Inc. (TSXV: AVE), meanwhile, reported a nearly 500% surge in its second-quarter revenue to a record $52.1 million, while its net loss for the quarter shrunk to $1.3 million from $9.8 million during the same period last year. Aveda stock moved up 36% to $0.455 following the announcement.
Finally, Berkwood Resources Ltd. (TSXV: BKR) (FSE: BK2) shares rose 10% to $0.46 after the graphite explorer announced that drilling has begun on its Lac Gueret South Graphite Project located in Quebec.
Related: Berkwood Resources Ltd. Set to Drill its Promising Graphite Property, Says Ubika Research
Ubika Research/SmallCapPower has received compensation from Berkwood Resources Ltd. (TSXV: BKR) (FSE: BK2) to provide analyst research coverage. For full disclosure please visit here >>.
Hi, did you know SmallCapPower accepts blog submissions? You can contact me here
Disclosure:
The Content contained on this page (including any facts, views, opinions, recommendations, description of, or references to, products or securities) made available by SmallCapPower/Ubika Research is for information purposes only and is not tailored to the needs or circumstances of any particular person. Any mention of a particular security is merely a general discussion of the merits and risks associated there with and is not to be used or construed as an offer to sell, a solicitation of an offer to buy, or an endorsement, recommendation, or sponsorship of any entity or security by SmallCapPower/Ubika Research. To read more of this Disclaimer please click on the button below: